Table 1 Association of WTX expression with clinicopathological characteristics of gastric cancer
Clinicopathological variables | WTX expression (%) | P-value | |
|---|---|---|---|
Negative | Positive | ||
Age (years) | |||
 < 60 | 58 (79.5) | 15 (20.5) | 0.438 |
 ≥ 60 | 48 (73.8) | 17 (26.2) | |
Gender | |||
 Male | 72 (75.0) | 24 (25.0) | 0.447 |
 Female | 34 (81.0) | 8 (19.0) | |
Tumor depth | |||
 T1 | 6 (85.7) | 1 (14.3) | 0.492 |
 T2 | 20 (71.4) | 8 (28.6) | |
 T3 | 73 (78.5) | 20 (21.5) | |
 T4 | 6 (60.0) | 4 (40.0) | |
Lymph node | |||
 - | 22 (56.4) | 17 (43.6) | 0.000∗ |
 + | 84 (84.8) | 15 (15.2) | |
Histological grade | |||
 Well | 15 (68.2) | 7 (31.8) | 0.011∗ |
 Moderate | 18 (62.1) | 11 (37.9) | |
 Poor | 75 (86.1) | 12 (13.9) | |
Stages | |||
 I | 20 (77.0) | 6 (23.0) | 0.361 |
 II | 43 (70.5) | 18 (29.5) | |
 III | 35 (85.4) | 6 (14.6) | |
 IV | 7 (70.0) | 3 (30.0) | |
Overall survival | |||
 Alive | 76 (36.4) | 31 (63.6) | 0.006∗ |
 Death | 28 (90.3) | 3 (9.7) | |